Cargando…

The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients

INTRODUCTION: Although the clinical effects of infliximab therapy in rheumatoid arthritis have been documented extensively, the biological effects of this intervention continue to be defined. We sought to examine the impact of infliximab therapy on the serum proteome of rheumatoid arthritis patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dwivedi, Ravi C, Dhindsa, Navjot, Krokhin, Oleg V, Cortens, John, Wilkins, John A, El-Gabalawy, Hani S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688177/ https://www.ncbi.nlm.nih.gov/pubmed/19265537 http://dx.doi.org/10.1186/ar2637

Ejemplares similares

Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis
por: El-Gabalawy, Hani S, et al.
Publicado: (2004)

Quantification of the Host Response Proteome after Mammalian Reovirus T1L Infection
por: Berard, Alicia R., et al.
Publicado: (2012)

Serum proteomic networks associate with pre-clinical rheumatoid arthritis autoantibodies and longitudinal outcomes
por: O’Neil, Liam J., et al.
Publicado: (2022)

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: O’Neil, Liam J., et al.
Publicado: (2021)

Oxidation in rheumatoid arthritis
por: Hitchon, Carol A, et al.
Publicado: (2004)

The Synovium in Rheumatoid Arthritis
por: Hitchon, Carol A, et al.
Publicado: (2011)

The identification and characterization of a novel protein, c19orf10, in the synovium
por: Weiler, Tracey, et al.
Publicado: (2007)

Infliximab in the treatment of rheumatoid arthritis
por: Perdriger, A
Publicado: (2009)

A proteomic evaluation of urinary changes associated with cardiopulmonary bypass
por: Dwivedi, Ravi C., et al.
Publicado: (2016)

Why do we not have a cure for rheumatoid arthritis?
por: El-Gabalawy, Hani D, et al.
Publicado: (2002)

Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab
por: Magiera, Michal, et al.
Publicado: (2011)

Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients
por: Jurado, Teresa, et al.
Publicado: (2017)

How does infliximab work in rheumatoid arthritis?
por: Maini, Ravinder N, et al.
Publicado: (2002)

Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention
por: Maisha, Jeba Atkia, et al.
Publicado: (2023)

Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab Treatment
por: Selaas, Oddgeir, et al.
Publicado: (2015)

Infliximab improves vascular stiffness in patients with rheumatoid arthritis
por: Wong, M, et al.
Publicado: (2008)

Proteomic analysis of Clostridium thermocellum core metabolism: relative protein expression profiles and growth phase-dependent changes in protein expression
por: Rydzak, Thomas, et al.
Publicado: (2012)

Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis
por: Anaparti, Vidyanand, et al.
Publicado: (2019)

Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy
por: Lu, Yun-Chi, et al.
Publicado: (2019)

Dendritic Nanotheranostic for the Delivery of Infliximab: A Potential Carrier in Rheumatoid Arthritis Therapy
por: Rodríguez-Prieto, Tamara, et al.
Publicado: (2020)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study
por: Ortea, Ignacio, et al.
Publicado: (2016)

Disparities in rheumatoid arthritis outcomes for North American Indigenous populations
por: Hitchon, Carol A, et al.
Publicado: (2023)

The synovial proteome: analysis of fibroblast-like synoviocytes
por: Dasuri, Kumar, et al.
Publicado: (2004)

A systematic review of infliximab in the treatment of early rheumatoid arthritis
por: Du Pan, Sophie Martin, et al.
Publicado: (2007)

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
por: Crnkic, Meliha, et al.
Publicado: (2003)

Ankylosing Spondylitis and Rheumatoid Arthritis: Serum Levels of TNF-α and Its Soluble Receptors during the Course of Therapy with Etanercept and Infliximab
por: Schulz, Martin, et al.
Publicado: (2014)

Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis
por: Hu, Congqi, et al.
Publicado: (2022)

Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany
por: Waller, John, et al.
Publicado: (2017)

Proteomics-based metabolic modeling and characterization of the cellulolytic bacterium Thermobifida fusca
por: Vanee, Niti, et al.
Publicado: (2014)

Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
por: Mugnier, B, et al.
Publicado: (2004)

Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab
por: Mori, Shunsuke, et al.
Publicado: (2011)

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
por: Mulleman, Denis, et al.
Publicado: (2009)

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
por: Bobbio-Pallavicini, Francesca, et al.
Publicado: (2004)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
por: Dénarié, Delphine, et al.
Publicado: (2017)

Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
por: Akhlaghi, Saeed, et al.
Publicado: (2019)

Recurrent and refractory corneal perforation secondary to rheumatoid arthritis treated with infliximab
por: Al Saleh, Ahmed, et al.
Publicado: (2021)

Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts
por: Turner-Brannen, Emily, et al.
Publicado: (2011)

Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
por: Rosenberg, Alexander, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nj1bh5nunl46d9k2m0g2hsj9to